Egg phospholipids for injection CAS: 93685-90-6

Meglumine CAS: 6284-40-8

Propofol CAS: 2078-54-8

Retatrutide/GIPR/GLP-1R  CAS: 2381089-83-2

Tirzepatide CAS: 2023788-19-2

Esaxerenone (CAS 1632006-28-0) is a GMP-compliant, high-purity active pharmaceutical ingredient (API), a highly selective non-steroidal mineralocorticoid receptor antagonist (MRA). Approved in Japan for primary hypertension and type 2 diabetic nephropathy treatment, it delivers robust antihypertensive efficacy with reduced endocrine side effects, fully complying with ICH, JP and USP pharmacopoeia standards.

Cagrilintide CAS: 1415456-99-3

Lemborexant (CAS 1369764-02-2) is a high-purity, GMP-compliant dual orexin receptor antagonist (DORA) API. It is clinically indicated for the treatment of insomnia disorder in adults, improving sleep onset and maintenance with favorable next‑day residual effects. It complies with ICH, USP and EP pharmacopoeial standards.

Mirogabalin Besylate (CAS 1138245-21-2) is a GMP-compliant, high-purity API, a selective α2δ-1 ligand of voltage-gated calcium channels. Approved for peripheral neuropathic pain (diabetic peripheral neuropathic pain & postherpetic neuralgia), it delivers sustained analgesia with favorable CNS safety, meeting ICH, JP, and USP pharmacopoeial standards.

Linaclotide CAS: 851199-59-2

Plecanatide CAS: 467426-54-6

Diquafosol Tetrasodium (CAS: 211427-08-6) is a GMP-compliant, high-purity selective P2Y2 purinergic receptor agonist API. It promotes tear and mucin secretion to repair ocular surface damage, approved for dry eye disease treatment. It fully meets ICH, JP, USP and EP pharmacopoeial standards, ideal for ophthalmic eye drop formulation R&D and commercial manufacturing.